FTH — Faeth Therapeutics Share News
0.000.00%
Last trade - 00:00- $519.39m
- $332.95m
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments
Faeth Therapeutics, Inc reports results for the quarter ended June 30 - Earnings Summary
Faeth Therapeutics, Inc expected to post a loss of $3.62 a share - Earnings Preview
Brief: Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
NASDAQ RESUMED AT 03:41 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:31 PM
U.S. RESEARCH ROUNDUP-American Tower, H.B. Fuller Company, TD Synnex
Brief: Sensei Biotherapeutics Announces Name Change To Faeth Therapeutics
Brief: Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
Brief: Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
NASDAQ RESUMED AT 10:01 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:49 AM
NASDAQ RESUMED AT 10:03 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:53 AM